Citadel Advisors’s CareMax, Inc. Class A Common Stock CMAX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-203
Closed -$3.04K 15902
2023
Q4
$3.04K Buy
203
+150
+283% +$6.23K ﹤0.01% 13635
2023
Q3
$3.39K Buy
+53
New +$3.71K ﹤0.01% 13592
2023
Q1
Sell
-517
Closed -$56.6K 16265
2022
Q4
$56.6K Buy
517
+170
+49% +$25.4K ﹤0.01% 11973
2022
Q3
$74K Buy
+347
New +$70.1K ﹤0.01% 11339

Other funds holding CMAX

Citadel Advisors's CMAX Position: Q1 2024 in Review

Citadel Advisors sold out of CareMax, Inc. Class A Common Stock (CMAX) in Q1 2024, closing a stake of 2,824 shares — an estimated $42.2K sold.

Citadel Advisors first reported a position in CMAX in Q3 2021 and held it in 8 quarters. The position peaked at $1.99M in Q2 2022. 42 funds tracked by Wall St. Rank hold CMAX as of Q1 2024.

  • Citadel Advisors reported no remaining CareMax, Inc. Class A Common Stock position as of Q1 2024 after selling out during the quarter.
  • Citadel Advisors sold 2,824 CareMax, Inc. Class A Common Stock shares in Q1 2024, an estimated $42.2K.
  • Citadel Advisors first reported a position in CareMax, Inc. Class A Common Stock in Q3 2021 and held it in 8 quarters.
  • Citadel Advisors's CareMax, Inc. Class A Common Stock position peaked at $1.99M in Q2 2022.
  • 42 funds tracked by Wall St. Rank held CareMax, Inc. Class A Common Stock as of Q1 2024.

Based on Citadel Advisors's 13F filing for Q1 2024, filed 15 May 2024.